Evidence map›Paper›PMID 38964925›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2024

[Clinical characteristics and prognostic analysis of 34 patients with primary thyroid lymphoma].

L Yang, L J Zeng, J Ye, L Q Wei, J Cong, X Li, N Yao, J Yang, H N Wang, L W Lyu and 2 more

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

L YangDepartment of Hematology, Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing 100730, China.
L J ZengDepartment of Hematology, Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing 100730, China.
J YeDepartment of Hematology, Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing 100730, China.
L Q WeiDepartment of Hematology, Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing 100730, China.
J CongDepartment of Hematology, Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing 100730, China.
X LiDepartment of Hematology, Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing 100730, China.
N YaoDepartment of Hematology, Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing 100730, China.
J YangDepartment of Hematology, Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing 100730, China.
H N WangDepartment of Hematology, Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing 100730, China.
L W LyuDepartment of Hematology, Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing 100730, China.
Y P WuDepartment of Hematology, Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing 100730, China.
L WangDepartment of Hematology, Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing 100730, China.

Funding

National Key Research and Development Program of China 2022YFF1502000National Natural Science Foundation of China 82170181, 82370188Natural Science Foundation of Beijing 7222027
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lymphoma, B-Cell, Marginal ZoneLymphoma, Large B-Cell, DiffuseThyroid NeoplasmsAdultFemaleHumansMaleMiddle AgedPrognosisRetrospective StudiesSurvival RatePathological diagnosisPrimary thyroid lymphomaRisk factorsTreatment efficacy evaluation

Identifiers

PMID38964925
PMCPMC11270499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.